Two weeks ago, the government of Argentina gained final legislative approval of a bill allowing for the medicinal use of cannabis oil. This legislation also permits cannabis to be grown for both research and therapeutic purposes. The unanimously approved bill helps to establish a means for scientific exploration of the effectiveness of marijuana to treat numerous diseases, as well as a way for Argentina to provide medical cannabis to patients free of charge.
Medical marijuana companies will likely tap the Canadian bond market to fund growth as investors become more comfortable with the industry and the federal government gets set to legalize the drug by next year.
“There would be an appetite for more traditional debt arrangements and, given that leading cannabis companies have significant assets now, this may be one direction that we see the market go in the future,” said Cam Battley, executive vice president of Aurora Cannabis Inc., a licensed marijuana producer in Mountain View County, Alberta. “I suspect we’re headed in that direction right now.”
Two weeks ago, the government of Argentina gained final legislative approval of a bill allowing for the medicinal use of cannabis oil. This legislation also permits cannabis to be grown for both research and therapeutic purposes. The unanimously approved bill helps to establish a means for scientific exploration of the effectiveness of marijuana to treat numerous diseases, as well as a way for Argentina to provide medical cannabis to patients free of charge.
Courtesy of Ted Chung Snoop Dogg With the legal cannabis industry generating $6.9 billion in sales in 2016, up 34% from 2015, it’s a no-brainer to say that much is at stake as the business inevitably grows. Much like the independent movie biz, the cannabis industry attracts investors looking for high-risk, high-reward investments, and as marijuana goes more mainstream, so does the funding mechanisms for the industry’s businesses.
MJIC Inc. has added five new companies to the U.S. Marijuana Index as a result of its quarterly rebalancing.
The post Here Are The 5 Stocks Added To The U.S. Marijuana Index appeared first on Marijuana Industry News.
In March, Congress introduced legislation to regulate and tax marijuana, and to remove it from the federal Controlled Substances Act.
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has filed patent applications for IGC-501 in Canada, Israel and Europe in support of its ongoing cannabis-based combination therapy development initiatives.
Saturday, April 8, 2017
Bipartisan legislation proposed in the House on Thursday would make marijuana a Schedule 3 drug, removing cannabis from its current standing as a Schedule 1 substance alongside deadly contraband including ecstasy and heroin.
By reclassifying weed in the same category as anabolic steroids, Congress would “make it easier for ill-patients and scientific and medical researchers to obtain marijuana,” the bill’s authors said in a statement Thursday.
America's neighbor to the north is fast moving toward legalizing recreational marijuana nationwide, which would make Canada the second country in the world to do so. And the impact of having weed legalized on such a big scale, so close to home, may affect the future of pot in the United States. "There are those who sometimes regard Canada as the 51st state. It would be an important signal about the movement coming of age.
"There are those who sometimes regard Canada as the 51st state. It would be an important signal about the movement coming of age. It would add to the critical mass,” says Oregon Rep. Earl Blumenauer, a member of Congress' newly-formed Cannabis Caucus who is pushing to change the way the federal government treats the substance. And, he says: "It would shift the center of gravity."
Since its inception in 2005, India Globalization Capital (NYSE: IGC) has transitioned from a mining company to a developer of cannabis-based therapies. The company is unique in that it uses cannabis-based extracts in combination with other medications to reduce side effects and increase bioavailability and absorption.
This move would be highly beneficial for SinglePoint, Inc. (OTC: SING), a leading mobile technology and payment solutions company that provides ancillary services to the marijuana industry.
A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline.
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the sale of its investment interest in Brilliant Hallmark for a consideration of four million shares of IGC.
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its investment in Breakwater MB, LLC, a cannabis-focused investment and consulting company formed by CIIX board member and former CFO Paul Dickman.
There are a number of advantages to society and the public safety in regulating marijuana, but economic arguments also favor its legalization.
